Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Molly Lehmann"'
Autor:
Michelle A Chui, Jen Birstler, David Goodrich, Edward Portillo, Molly Lehmann, Timothy Hagen, Martha Maurer, Jordyn Kettner, Sonia Bhardwaj, M Shawn McFarland, Natasha Virrueta, Blake Henderson
Publikováno v:
BMJ Open Quality, Vol 12, Iss 1 (2023)
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide and is estimated to be the leading cause of death in the next 15 years. Patients with COPD suffer from persistent chronic cough, sputum production and exacerba
Externí odkaz:
https://doaj.org/article/68908462ba1f4c0e97e2107e554c89a6
Autor:
Sonia Bhardwaj, Stephanie Garvin, Sierra Kuehl, Johanna Van Epps, Frederick Dunkerson, Molly Lehmann, Stephanie Gruber, Mara Kieser, Qianqian Zhao, Edward Christopher Portillo
Publikováno v:
INNOVATIONS in Pharmacy, Vol 13, Iss 3 (2022)
Background: Proton pump inhibitors (PPIs) are among the most widely prescribed class of medications in the United States. Although effective in the treatment of acid related disease, inappropriate PPI use is prevalent, and long-term PPI use has been
Externí odkaz:
https://doaj.org/article/0d4ff895454b4ddaa775605973e61909
Publikováno v:
Annals of Pharmacotherapy. 57:241-250
Background: Escalating doses of insulin required with progression of type 2 diabetes may lead to weight gain. Weight loss associated with semaglutide may be beneficial. However, data on the use of semaglutide in patients requiring high daily doses of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e3048ef10ec06548f114980f0e9a72c
https://doi.org/10.1177/10600280221107381
https://doi.org/10.1177/10600280221107381
Autor:
Amanda Margolis, Kelsey Kreyer, Rangana Milone, Edward C. Portillo, Sujani Kakumanu, Kim Kies, Molly Lehmann, Stephanie Gruber
Publikováno v:
Journal of the American Pharmacists Association. 61:e129-e135
Background Chronic obstructive pulmonary disease (COPD) is the third leading cause of death globally and a common cause of hospital readmissions in the United States. While best practices exist in COPD management, incorporation of such approaches int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b2cc6eb3c175f0de41ac248e11b022d
https://doi.org/10.1016/j.japh.2020.10.023
https://doi.org/10.1016/j.japh.2020.10.023
Autor:
Edward Portillo, Molly Lehmann, Timothy Hagen, Martha Maurer, Jordyn Kettner, Sonia Bhardwaj, David Goodrich, M Shawn McFarland, Natasha Virrueta, Blake Henderson, Jen Birstler, Michelle A Chui
Publikováno v:
BMJ Open Quality. 12:e002074
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide and is estimated to be the leading cause of death in the next 15 years. Patients with COPD suffer from persistent chronic cough, sputum production and exacerba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67500ac0142db568dbb98124327497e6
https://doi.org/10.1136/bmjoq-2022-002074
https://doi.org/10.1136/bmjoq-2022-002074
Autor:
Frederick Dunkerson, Edward C. Portillo, Maria Wopat, Katherine Rothbauer, Ellina Seckel, Erica Wagner, Kevin A. Look, Stephanie Gruber, Jodi Meyer, Molly Lehmann
Publikováno v:
Currents in pharmacy teachinglearning. 13(8)
Background As healthcare continues to become more complex, pharmacist innovators have worked to advance the profession and expand the role of the pharmacist on the healthcare team. Accreditation standards for schools of pharmacy recognize the importa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b4bb83faf54ce1346b515ca207cb959
https://pubmed.ncbi.nlm.nih.gov/34294264
https://pubmed.ncbi.nlm.nih.gov/34294264